Sorin strengthens lead business as financial shockwaves recede
This article was originally published in Clinica
Executive Summary
Italian cardiovascular company Sorin has acquired OEM cardiac device firm Oscor’s lead business for $20m. The deal includes Tampa, Florida-based Oscor’s manufacturing facility in the Dominican Republic. Sorin was previously one of Oscor’s OEM clients, with the latter producing its MRI-compatible brady leads. The Italian firm believes the deal will allow further co-development opportunities for similar brady and tachy leads. For its part, Oscor will now focus on its catheters business and custom OEM lead development.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.